New York Presbyterian/Weill Cornell is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian/Weill Cornell has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Solid Tumors, Cirrhosis, Cirrhosis, Liver.
Sponsors: Incyte Corporation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Northwestern University.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian/Weill Cornell has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian/Weill Cornell has 4 clinical trials on record, with 3 currently active. Their work covers Solid Tumors, Cirrhosis, Cirrhosis, Liver.
Yes — New York Presbyterian/Weill Cornell holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.